The insider sales are routine and non-informative at this scale. Monitor for any material corporate events (pipeline data, partnership, financing) that could drive the stock, but this cluster alone provides no actionable signal. The historical underperformance of prior STOK reports suggests caution in over-interpreting any single filing.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 19 $33.03entry
- T+1 · 3mo ago −4.93%α −4.09% · $31.40
- T+5 · 3mo ago +0.18%α +0.57% · $33.09
- T+20 · 2mo ago −12.41%α −10.46% · $28.93
- T+60 · 5d ago −20.68%α −19.13% · $26.20
Price Chart
How similar events traded
Executive Summary
Two Stoke Therapeutics insiders, a director and the general counsel, executed open-market sales totaling $469K on August 18, 2026, following the exercise of stock options on August 14. The sales represent ~0.02% of the $2.1B market cap, a trivial amount that does not signal material bearish conviction. The option exercises (non-cash) and same-day open-market sales are consistent with routine tax-covering or liquidity-driven transactions, not informed selling. Given the trivial proportionality and weak historical signal, this cluster is neutral.
Key Financial Metrics
Key Facts
- Director Kaye sold 11,930 shares at $32.01 for $382K on Aug 18, 2026
- General Counsel Allan sold 2,716 shares at $32.01 for $87K on Aug 18, 2026
- Both insiders exercised stock options (non-cash) on Aug 14, 2026 before selling
- Total open-market sales = $469K, representing ~0.02% of $2.1B market cap
- Sales are trivial relative to market cap and consistent with liquidity/vesting-driven activity
Financial Impact
Total insider sales of $469K, ~0.02% of market cap, immaterial
Risk Factors
- Insider sales could accelerate if insiders hold more unexercised options
- No material bearish signal from this cluster, risk of false negative if ignoring other negative catalysts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-STOK-1787099375451 |
Track record
18 reports on STOK
3 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +17.49% at T+60 after the Aug 3, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $27.02 Now $26.63 −1.44% settles Feb 12
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $26.12 Now $26.63 +1.95% settles Feb 12
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $26.07 Now $26.63 +2.15% settles Feb 3
- Oct 29, 202618d ago 8-K Neutral 5/10 Entry $26.29 Now $26.63 +1.29% settles Jan 28
- Oct 21, 202626d ago 144 Bearish 6/10 Entry $25.70 Now $26.63 −3.62% settles Jan 20
- Sep 30, 20266w ago SC 13G Neutral 4/10 Entry $26.01 Now $26.63 +2.38% settles Dec 28
- Sep 25, 20267w ago 8-K Neutral 2/10 Entry $25.50 Now $26.63 +4.43% settles Dec 22
- Aug 18, 202612w ago Insider Cluster Neutral 3/10 Viewing Entry $33.03 to $26.20 Now $26.63 −19.38% ▼ −20.68% −19.13% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers